Bruker
BRKR · Health Care Equipment
$57.59
0.5%Revvity
RVTY · Health Care Equipment
$158.77
0.9%The short version
- Bruker is the larger business, with $3.4B of revenue in fiscal 2025 against $2.9B for Revvity.
- Revvity grew revenue faster (3.7%, against 2.1%).
- Revvity kept more of each dollar of sales as operating profit (12.5% operating margin, against 2.0% operating margin).
- Revvity turned more of its sales into free cash flow (17.8% FCF margin, against 1.3% FCF margin).
- Revvity earned a higher return on the capital invested in it (3.3%, against 0.9%).
| Latest fiscal year | BRKR · FY25 | RVTY · FY25 |
|---|---|---|
| Size | ||
| Market cap | $8.8B | $17.7B |
| Revenue | $3.4B | $2.9B |
| Free cash flow | $43.3M | $509M |
| Net income | −$8.6M | $241M |
| Growth | ||
| Revenue growth | 2.1% | 3.7% |
| 5-year growth | 11.6% | −5.5% |
| Share count change | 1.5% | −5.1% |
| Profitability | ||
| Gross margin | 45.9% | — |
| Operating margin | 2.0% | 12.5% |
| Net margin | −0.3% | 8.5% |
| FCF margin | 1.3% | 17.8% |
| Return on capital | 0.9% | 3.3% |
| Return on equity | −0.4% | 3.2% |
| Balance sheet | ||
| Net debt | $1.6B | $2.3B |
| Net debt / EBITDA | 5.5x | 3.0x |
| Dividends and buybacks | $32.8M | $854M |
| Valuation & quality | ||
| P/E | — | 76.0x |
| Piotroski F-score | 4 | 5 |
FY16
BRKR $1.6B
RVTY $2.1B
FY17
BRKR $1.8B
RVTY $2.3B
FY18
BRKR $1.9B
RVTY $2.8B
FY19
BRKR $2.1B
RVTY $2.9B
FY20
BRKR $2.0B
RVTY $3.8B
FY21
BRKR $2.4B
RVTY $3.8B
FY22
BRKR $2.5B
RVTY $3.3B
FY23
BRKR $3.0B
RVTY $2.8B
FY24
BRKR $3.4B
RVTY $2.8B
FY25
BRKR $3.4B
RVTY $2.9B
BRKR
RVTY
FY16
BRKR 11.3%
RVTY 13.9%
FY17
BRKR 12.4%
RVTY 13.1%
FY18
BRKR 13.8%
RVTY 11.7%
FY19
BRKR 14.5%
RVTY 12.6%
FY20
BRKR 12.5%
RVTY 22.9%
FY21
BRKR 17.1%
RVTY 32.9%
FY22
BRKR 17.1%
RVTY 22.4%
FY23
BRKR 14.7%
RVTY 10.9%
FY24
BRKR 7.5%
RVTY 12.6%
FY25
BRKR 2.0%
RVTY 12.5%
BRKR
RVTY
FY16
BRKR $93.7M
RVTY $319M
FY17
BRKR $111M
RVTY $249M
FY18
BRKR $191M
RVTY $218M
FY19
BRKR $140M
RVTY $287M
FY20
BRKR $235M
RVTY $829M
FY21
BRKR $190M
RVTY $1.3B
FY22
BRKR $145M
RVTY $594M
FY23
BRKR $243M
RVTY $9.9M
FY24
BRKR $136M
RVTY $542M
FY25
BRKR $43.3M
RVTY $509M
BRKR
RVTY
FY16
BRKR 21.2%
RVTY 9.1%
FY17
BRKR 14.9%
RVTY 4.4%
FY18
BRKR 23.8%
RVTY 6.9%
FY19
BRKR 21.6%
RVTY 7.7%
FY20
BRKR 16.6%
RVTY 13.6%
FY21
BRKR 25.1%
RVTY 11.0%
FY22
BRKR 21.0%
RVTY 5.1%
FY23
BRKR 17.5%
RVTY 2.7%
FY24
BRKR 4.8%
RVTY 3.1%
FY25
BRKR 0.9%
RVTY 3.3%
BRKR
RVTY
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.